CCL2 and malaria: Results revealed significantly higher MCP-1/CCL-2 levels in participants with severe Plasmodium infections compared to those with non-severe malaria (P: 0.04, SMD: 1.51, 95% CI: 0.06–2.95, I2: 98.5%, number of participants: 1371, Fig. 3).